Cancer Viral Therapy Attacks Tumors And Does Not Harm Healthy Tissue
9/01/2011
Intravenous viral therapy has been shown to consistently infect tumors without damaging healthy human tissue, according to a clinical trial published in the journal Nature. The authors say this is the first trial to test viral therapy on humans with cancer. They added that it is also the first trial to demonstrate tumor-selective expression of a foreign gene after intravenous administration...
A Step Toward A Saliva Test For Cancer
9/01/2011
A new saliva test can measure the amount of potential carcinogens stuck to a person's DNA interfering with the action of genes involved in health and disease and could lead to a commercial test to help determine risks for cancer and other diseases, scientists reported here today during the 242nd National Meeting & Exposition of the American Chemical Society (ACS)...
Choice Of Seizure Drug For Brain Tumor Patients May Affect Survival
9/01/2011
New research suggests brain tumor patients who take the seizure drug valproic acid on top of standard treatment may live longer than people who take other kinds of epilepsy medications to control seizures. The research is published in the August 31, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology...
'Pink Ribbon Dollars' Help Fill Financial Gaps For Breast Cancer Programs
9/01/2011
A new study shows that donations collected by check boxes on state income tax forms, fees from license plates and revenue from state lottery tickets have raised millions for breast cancer research and prevention programs across the country, according to researchers at Washington University in St. Louis...
Reporting On The Role Of Soy In Menopausal Health
9/01/2011
Discussion of a scientific review of soy protein, soy isoflavones and soy metabolites for peri- and postmenopausal women at North American Menopause Society (NAMS)/Wulf H...
Cancer Viral Therapy Attacks Tumors And Does Not Harm Healthy Tissue
8/31/2011
Intravenous viral therapy has been shown to consistently infect tumors without damaging healthy human tissue, according to a clinical trial published in the journal Nature. The authors say this is the first trial to test viral therapy on humans with cancer. They added that it is also the first trial to demonstrate tumor-selective expression of a foreign gene after intravenous administration...
Patients' Underlying Health Linked To Worse Outcomes For Melanoma
8/31/2011
It's not how old but how frail patients are that can predict how well they will fare after a melanoma diagnosis. In fact, young patients in poor health may have worse outcomes than older patients in good shape...
Black, Hispanic, Poor Young Women Less Likely To Complete HPV Vaccinations
8/31/2011
Barriers that hinder young African-American, Hispanic and poor women from completing a series of three vaccinations to prevent human papillomavirus infection (HPV) also leave them at higher risk for cervical cancer and death That is the conclusion of new study from the Yale School of Public Health that extends previous findings of the disparity in a nationally representative group...
Pediatric Cancers Targeted By Virus
8/31/2011
Researchers from Yale University are looking to a virus from the same family as the rabies virus to fight a form of cancer primarily found in children and young adults. They report their findings in the September 2011 issue of the Journal of Virology. Soft tissue sarcomas are cancers that develop in tissues which connect, support, or surround other structures and organs of the body...
Starving Breast Cancer Cells
8/31/2011
The most common breast cancer uses the most efficient, powerful food delivery system known in human cells and blocking that system kills it, researchers report. This method of starving cancer cells could provide new options for patients, particularly those resistant to standard therapies such as tamoxifen, Georgia Health Sciences University researchers said...